Quick intake
Health history, current medications, goals, and peptide experience. Takes about ten minutes from your phone.
Whether you're already running research peptides or you're new to the category, the upgrade is the same: pharmacy-compounded vials, dosing built off your own bloodwork, and a doctor who can actually see your numbers - shipped cold-chain to your door each month.
Available today: Sermorelin, NAD+, LDN, Glutathione, Gonadorelin. 7+ more queued for FDA reclassification - founding members get first call.
No payment required - join the free waitlist and we'll notify you at launch. A doctor evaluation is required before any prescriptions. Compounded medications are not FDA-approved.
Want your rate locked in forever and priority access? Become a founding member
We'll send a launch notification when we go live. Founding members keep their rate forever and get priority access - you can lock that in anytime.
$50 - applied to your first month. Full refund anytime before launch.
Four clear steps. No clinic visits, no gray area. Prescribing decisions are made independently by a licensed doctor based on your evaluation and bloodwork.
Health history, current medications, goals, and peptide experience. Takes about ten minutes from your phone.
Labs at any Quest location near you. This is what separates dosing based on your body from dosing based on a forum post.
Video visit with a licensed doctor who reviews your labs and evaluates whether peptide therapy is appropriate, and which plan fits your case.
If a prescription is issued, peptides are compounded at a US-licensed 503A pharmacy and shipped to your door each month, typically with insulated cold-pack packaging to keep medications stable in transit. Dosing is adjusted over time based on follow-up labs.
Compounded medications are not FDA-approved. A doctor evaluation is required before any prescriptions are issued. Your $50 founding deposit is fully refundable - applied to your first month if you move forward, refunded in full if you don't.
Add your email and we'll let you know the moment we go live - no payment required. Prefer to lock your rate in forever, with first access and priority for BPC-157 & TB-500 when they return? Founding members get all three - the $50 deposit is fully refundable anytime before launch and applied to your first month.
No payment required. You'll be notified at launch - but pricing and consultation priority are not reserved. A doctor evaluation is required before any prescriptions. Compounded medications are not FDA-approved.
Founding member pricing ends at launch.
You'll get a launch notification when we go live. Locked-in pricing and priority consultation access are reserved for founding members only.
$50 - applied to your first month. Full refund anytime before launch.
You know what BPC-157 does. You have done the research. But you have also wondered about the purity of that last vial, guessed at your dose, and had zero medical oversight. Here is the side-by-side.
Overseas labs. CoAs you cannot verify. "Not for human consumption" labels with a wink. You dose from forum posts, have no doctor, and have no recourse if something is wrong.
$400 - 500+ per month per peptide. In-office visits. Luxury wellness branding most people do not want. Telehealth alternatives won't even show pricing until you book a consult.
A 2024 FDA review paused pharmacy compounding for several popular peptides pending reclassification. Even if access returns, there is still no clear, affordable path to a real prescription.
That is the gap. Not another wellness brand. Not another clinic. Just a clean path from research chemicals to pharmacy-grade, doctor-supervised, dosed to your actual bloodwork, and priced like it should have been all along.
- The PeptidePrescript team
Most peptide clinics won't show you pricing until you book a consultation. We think that's backwards. Here's exactly what it costs: one monthly price that bundles doctor, labs, peptides, and shipping. No surprise charges.
Research peptides look cheap until you add the labs you run separately, the purity you cannot verify, and the doctor you do not have.
| PeptidePrescript | What you pay now* | Telehealth avg. | In-person clinics | |
|---|---|---|---|---|
| 1 peptide + doctor + labs | $249/mo | $40 - 80/mo* | $200 - 400/mo | $350 - 500/mo |
| 2 peptides + doctor + labs | $299/mo | $80 - 150/mo* | $350 - 600/mo | $600 - 900/mo |
| Purity testing | USP 795/797 compliant | None | Varies | USP standard |
| Doctor oversight | Included | None | Included | Included |
| Legal status | Legal Rx | Gray area | Legal Rx | Legal Rx |
| Pricing visible upfront | Yes - on this page | Varies | Usually after consult | After office visit |
*Research chemical pricing does not include the labs you run separately, the doctor you do not have, or the purity testing you cannot verify. Prices reflect publicly available data as of early 2026.
Five available for prescription now. Twelve more expected back after the HHS-announced reclassification formally publishes. If you have used it, we are either offering it today or ready to offer it the moment the FDA finalizes.
Each prescription is compounded specifically for your dose, in a US-licensed 503A pharmacy.
The most well-studied GHRH analog available for compounding. Studied for growth hormone optimization, sleep quality, body composition, and recovery.
Available nowAn FDA-approved substance prescribed off-label at low doses. Studied for immune modulation and inflammation support. No injection required.
Available nowCoenzyme involved in cellular energy metabolism. Available in injectable and sublingual formulations through licensed compounding pharmacies. FDA is currently reviewing NAD+ for inclusion on the 503A bulks list - availability is subject to change.
Available nowEndogenous antioxidant with a USP monograph. Compounded in injectable form for doctor-directed use.
Available nowGnRH analog used in doctor-supervised hormonal support. Established compounding pathway.
Available nowHHS announced in February 2026 that ~14 of 19 Category 2 peptides are returning to Category 1. The formal FDA publication has not happened yet. We monitor the Federal Register daily and are ready to prescribe these the moment the reclassification finalizes.
The most in-demand recovery peptide. Studied for tissue repair, gut healing, and tendon and ligament support.
Reclassification pendingStudied for systemic tissue repair, inflammation reduction, and cardiac tissue support.
Reclassification pendingGHRH analog studied for sustained growth hormone release. Commonly paired with Ipamorelin.
Reclassification pendingGrowth hormone secretagogue studied for sleep quality, lean body composition, and recovery.
Reclassification pendingStudied for immune modulation and T-cell activation. Approved in 30+ countries outside the U.S.
Reclassification pendingPeptide fragment studied for fat metabolism and body composition without affecting blood sugar.
Reclassification pendingNeuropeptide studied for stress resilience, focus, and immune modulation. Nasal spray formulation.
Reclassification pendingNootropic peptide studied for BDNF enhancement, cognitive function, and neuroprotection.
Reclassification pendingAnti-inflammatory tripeptide studied for gut health and immune modulation.
Reclassification pendingMitochondrial peptide studied for metabolic regulation, insulin sensitivity, and exercise performance.
Reclassification pendingCopper peptide studied for skin remodeling, collagen synthesis, and wound healing.
Reclassification pendingTetrapeptide studied for telomerase activation, sleep cycle regulation, and anti-aging.
Reclassification pendingPeer-reviewed studies, regulatory updates, and plain-language guides on every peptide we offer - updated weekly.
Short chains of amino acids that signal your body's own processes. An introduction to how peptides work and why medical supervision matters.
Read articleFDA reclassification, Category 1 vs 2, and what the HHS announcement means for access to compounded peptides this year.
Read articleThe most well-studied GHRH analog available for compounding. How it works, what the clinical research shows, and how prescriptions are handled.
Read articleFDA reclassification updates, the research worth reading, and what's actually changing in compounded peptides. Free. No spam. Read in 4 minutes.
Free weekly newsletter. Unsubscribe anytime.
Watch your inbox for the next issue.